BSE Live
Oct 31, 16:01Prev. Close
910.00
Open Price
896.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:59Prev. Close
907.90
Open Price
907.90
Bid Price (Qty.)
904.45 (2)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Alivus Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 39.63 | 38.43 | 38.11 | 35.63 | 32.61 | |
| Diluted EPS (Rs.) | 39.53 | 38.38 | 38.11 | 35.63 | 32.61 | |
| Cash EPS (Rs.) | 44.58 | 42.79 | 41.55 | 37.27 | 392.83 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 229.92 | 190.35 | 174.51 | 167.66 | 768.11 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 229.92 | 190.35 | 174.51 | 167.66 | 768.11 | |
| Dividend / Share(Rs.) | 5.00 | 22.50 | 21.00 | 21.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 194.79 | 186.35 | 176.39 | 173.29 | 1,923.64 | |
| PBDIT/Share (Rs.) | 58.53 | 56.01 | 54.78 | 51.48 | 603.96 | |
| PBIT/Share (Rs.) | 53.58 | 51.65 | 51.35 | 48.39 | 569.89 | |
| PBT/Share (Rs.) | 53.38 | 51.52 | 51.30 | 46.11 | 480.56 | |
| Net Profit/Share (Rs.) | 39.63 | 38.43 | 38.11 | 34.17 | 358.76 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 30.04 | 30.05 | 31.05 | 29.70 | 31.39 | |
| PBIT Margin (%) | 27.50 | 27.71 | 29.11 | 27.92 | 29.62 | |
| PBT Margin (%) | 27.40 | 27.64 | 29.08 | 26.60 | 24.98 | |
| Net Profit Margin (%) | 20.34 | 20.62 | 21.60 | 19.72 | 18.64 | |
| Return on Networth / Equity (%) | 17.23 | 20.18 | 21.83 | 20.38 | 46.70 | |
| Return on Capital Employed (%) | 22.32 | 26.24 | 28.62 | 28.40 | 72.00 | |
| Return on Assets (%) | 14.23 | 16.51 | 17.28 | 16.94 | 17.60 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.76 | 0.82 | 0.84 | 0.95 | 1.01 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.97 | 4.37 | 3.67 | 4.60 | 1.15 | |
| Quick Ratio (X) | 3.53 | 2.85 | 2.47 | 3.25 | 0.73 | |
| Inventory Turnover Ratio (X) | 3.56 | 3.59 | 1.96 | 1.95 | 2.11 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 58.54 | 82.65 | 30.72 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 52.57 | 75.81 | 28.17 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 41.46 | 17.35 | 69.28 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 47.43 | 24.19 | 71.83 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 13,157.64 | 9,197.77 | 4,488.68 | 5,111.73 | 0.00 | |
| EV/Net Operating Revenue (X) | 5.51 | 4.03 | 2.08 | 2.41 | 0.00 | |
| EV/EBITDA (X) | 18.35 | 13.40 | 6.69 | 8.10 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 5.54 | 4.16 | 2.22 | 2.65 | 0.00 | |
| Retention Ratios (%) | 0.00 | 41.45 | 17.34 | 69.27 | 0.00 | |
| Price/BV (X) | 4.70 | 4.07 | 2.24 | 2.74 | 0.00 | |
| Price/Net Operating Revenue | 5.54 | 4.16 | 2.22 | 2.65 | 0.00 | |
| Earnings Yield | 0.04 | 0.05 | 0.10 | 0.07 | 0.00 |
05.08.2025
Alivus Life Standalone June 2025 Net Sales at Rs 601.85 crore, up 2.25% Y-o-Y
25.10.2024
Glenmark Life Standalone September 2024 Net Sales at Rs 506.88 crore, down 14.86% Y-o-Y
26.07.2024
Glenmark Life Standalone June 2024 Net Sales at Rs 588.62 crore, up 1.76% Y-o-Y
26.04.2024
Glenmark Life Standalone March 2024 Net Sales at Rs 536.60 crore, down 13.64% Y-o-Y